Camber Pharma Launches Generic Evista

PRESS RELEASE

Piscataway, NJ, September 26, 2014— Camber Pharmaceuticals announced Thursday that it has launched Raloxifene Hydrochloride, USP 60 mg tablets. The drug is the generic version of Evista® (raloxifene hydrochloride) tablets from Eli Lilly and Company. Raloxifene is available in 30 and 100 count bottles.

“Raloxifene is an important product addition in Camber’s portfolio, one of many we have planned in the coming months” said Kon Ostaficiuk, president of Camber. “Our continued growth as a leading generic supplier is a testament to our strong API manufacturing and the integrity of our supply chain.”

Camber Pharmaceuticals is a fully integrated international pharmaceutical company that maintains quality and integrity in all its products. Its parent company, Hetero Drugs of Hyderabad India, is one of the world’s leading API and finished dosage manufacturers. Camber’s commitment to the consumer is to bring the highest quality generic pharmaceuticals to the market to improve quality of life through cost-effective medications.